Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Serenoa repens may cause early puberty and should be used cautiously in children.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Potassium channel openers help form elastic fibers in arteries and can treat elastin deficiency and hypertension.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

AH-001 could be a safer and more effective treatment for hair loss.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

The FDA did not approve a testosterone drug because of safety concerns.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.